Skip to main content
. 2022 Dec 13;12:21496. doi: 10.1038/s41598-022-25405-w

Figure 2.

Figure 2

Creation of PARP1+/+ (U6) and PARP1−/− (SiP) cells for functional characterization. (a) Schematic representation for clone generation, selection, and isolation after PARP1 silencing using SiP and mock U6 shRNA control. Cells for experimentation were confirmed for absolute PARP1 depletion at passage 5. (b) Immunoblot confirmation of PARP-1 depletion in SiP and U6 cells. The graph represents quantification for PARP1 depletion in most established clones after 3 independent passages. Data represented as mean ± sem, p-value show significance at 95% confidence interval using ttest analysis compared to U6 cells (n = 3). (c) Phase contrast images for PARP1 control and deplete SiP-PANC-1 cells showing morphological changes after KD. Fluorescent staining show images for PARP-1 (green). (d) Immunocytochemistry images for pancreatic progenitor- nestin (red), pdx1 (green), and ngn-3 (red) in PANC-1 U6 and SiP cells.